Paul Tudor Jones’s GoHealth GOCO Stock Holding History

Paul Tudor Jones’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-16,313	Closed	-$927K	–	2260
2021 Q4	$927K	Buy	+16,313	New	+$1.09M	0.02%	1057
2021 Q2	–	Sell	-3,346	Closed	-$587K	–	1710
2021 Q1	$587K	Buy	+3,346	New	+$675K	0.01%	1082

Other funds holding GOCO

Centerbridge Partners New York $38.1M AUM 9.24% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Paul Tudor Jones's GOCO Position: Q1 2022 in Review

Paul Tudor Jones sold out of GoHealth (GOCO) in Q1 2022, closing a stake of 16,313 shares — an estimated $927K sold.

Paul Tudor Jones first reported a position in GOCO in Q1 2021 and held it in 2 quarters. The position peaked at $927K in Q4 2021. 112 funds tracked by Wall St. Rank hold GOCO as of Q1 2022.

Paul Tudor Jones reported no remaining GoHealth position as of Q1 2022 after selling out during the quarter.
Paul Tudor Jones sold 16,313 GoHealth shares in Q1 2022, an estimated $927K.
Paul Tudor Jones first reported a position in GoHealth in Q1 2021 and held it in 2 quarters.
Paul Tudor Jones's GoHealth position peaked at $927K in Q4 2021.
112 funds tracked by Wall St. Rank held GoHealth as of Q1 2022.

Based on Tudor Investment Corp's 13F filing for Q1 2022, filed 16 May 2022.